1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Deadline was November 25, 2024 at 11:59 p.m. PT — this cycle has already closed.
Rare Disease Research Grant Program - Amyloidosis is sponsored by National Organization for Rare Disorders (NORD). NORD offers a research grant for scientific and/or clinical research studies related to amyloidosis. This program provides seed money to qualified investigators for research of diseases with limited funding sources.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
National Organization for Rare Disorders (NORD) Announces $85,000 in Grant Funding for Amyloidosis and Levy-Yeboa Syndrome QUINCY, Mass. , Sept. 30, 2024 /PRNewswire/ -- Today, the National Organization for Rare Disorders (NORD ® ) announced two new requests for proposal (RFP) for grant funding related to Amyloidosis and Levy-Yeboa Syndrome (LYS).
NORD's Rare Disease Research Grant Program , established in 1989, provides seed money to qualified investigators for scientific and clinical research of diseases for which there are few other sources of funding. NORD, with donations from the amyloidosis community, is accepting applications for one grant of up to $45,000 US for scientific and/or clinical research studies related to amyloidosis .
The deadline for applications is November 25, 2024 at 11:59 p. m. PT .
Learn more and view application instructions here. NORD, with fundraising by the Maxwell Family, is accepting applications for one grant of up to $40,000 US for scientific and/or clinical research studies related to Levy-Yeboa syndrome (LYS) . The deadline for applications is November 25, 2024 at 11:59 p.
m. PT . Learn more and view application instructions here.
Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Ideally, the proposed research should have the potential to lead to the development of a new or better therapy.
To learn more or submit to the 2024 NORD Research Grants Cycle, visit the Rare Disease Research Grant Program page of the NORD website.
About the National Organization for Rare Disorders (NORD ® ) With a more than 40-year history of advancing care, treatments and policy, the National Organization for Rare Disorders (NORD) is the leading and longest-standing patient advocacy group for the more than 30 million Americans living with a rare disease. An independent 501(c)(3) nonprofit, NORD is dedicated to individuals with rare diseases and the organizations that serve them.
NORD, along with its more than 340 patient organization members, is committed to improving the health and well-being of people with rare diseases by driving advances in care, research and policy. For more information, visit rarediseases. org .
SOURCE National Organization for Rare Disorders (NORD) more press release views with
According to the current listing, eligibility includes: Qualified investigators affiliated with a host institution, with a terminal degree (MD, PhD, PharmD, or equivalent), developing their research careers in TTR Amyloidosis, and with a mentor or senior investigator partici…. Confirm the full requirements in the official notice before applying.
The current listing shows up to $45,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Rare Disease Research Grant Program - Amyloidosis is funded by National Organization for Rare Disorders (NORD). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Anthropic is giving rare-disease researchers and early-stage biotechs up to $50,000 in Claude API credits over six months — not cash, but compute. Here is how the two-track program works, who is eligible, what the credits can and cannot do, and how it fits a fast-growing new category: the compute-as-grant model reshaping how AI-for-science actually gets funded.
Read articleThe Department of Energy's Office of Critical Minerals and Energy Innovation is spending to break America's 95% dependence on foreign rare earths. The strategy is unusual: recover critical materials from the waste streams of coal plants, smelters, and refineries that already exist. Here is the full funding architecture — the $75M just awarded, the $500M battery-materials round, the $1B pipeline behind them — and how an industrial operator should position for what comes next.
Read articleOn June 2, 2026, the Department of Energy's Office of Critical Minerals and Energy Innovation selected two demonstration-scale facilities — Phoenix Tailings (with MIT and the University of Minnesota) for $66 million, and the Colorado School of Mines (with ElementUSA, PNNL, Principal Mineral, and Rare Earth Technologies Inc.) for the balance — under the Rare Earth Elements Demonstration Facility Program. Both projects pull rare earths from industrial waste — red mud at the Gramercy refinery in Louisiana, and a mix of mine and refining tailings elsewhere. Here is what the selections tell researchers, small businesses, and downstream magnet customers about where DOE thinks the chokepoint actually is, and what to do before the next demonstration-scale solicitation opens.
Read article